VisionPoint Advisory Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,375
Closed -$266K 464
2025
Q4
$266K Buy
3,375
+253
+8% +$20K 0.05% 323
2025
Q3
$257K Sell
3,122
-204
-6% -$16.1K 0.05% 327
2025
Q2
$267K Buy
+3,326
New +$257K 0.06% 288
2024
Q2
Sell
-51
Closed -$3.78K 857
2024
Q1
$3.78K Hold
51
﹤0.01% 588
2023
Q4
$3.37K Buy
+51
New +$3.19K ﹤0.01% 552

Other funds holding MET

VisionPoint Advisory Group's MET Position: Q1 2026 in Review

VisionPoint Advisory Group sold out of MetLife (MET) in Q1 2026, closing a stake of 3,375 shares — an estimated $266K sold.

VisionPoint Advisory Group first reported a position in MET in Q4 2023 and held it in 5 quarters. The position peaked at $267K in Q2 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • VisionPoint Advisory Group reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • VisionPoint Advisory Group sold 3,375 MetLife shares in Q1 2026, an estimated $266K.
  • VisionPoint Advisory Group first reported a position in MetLife in Q4 2023 and held it in 5 quarters.
  • VisionPoint Advisory Group's MetLife position peaked at $267K in Q2 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on VisionPoint Advisory Group's 13F filing for Q1 2026, filed 7 May 2026.